Risperdal Gynecomastia Lawsuits in 2015 Reveal Manufacturer’s Pursuit Of Profit Over Young Boys’ Safety
Written by Stephen Fields on May 12, 2015
For many parents, the atypical antipsychotic Risperdal seems like a godsend. It can help mitigate troublesome behavior in autistic children. Some parents with kids who are severely autistic rely on the drug to bring a sense of normalcy and predictability to their lives. But use of the medication isn’t without possible side effects. Scientific evidence has repeatedly shown a potential connection between Risperdal and abnormal breast enlargement in young boys.
The medication is manufactured by Johnson & Johnson and its subsidiary Janssen Pharmaceuticals. Although the FDA cleared it for sale in 1994, it wasn’t until 2006 that the watchdog agency approved it for use in children. But Johnson & Johnson, identifying a large potential market, didn’t wait. It promoted Risperdal for pediatric use long before it had clearance to do so.
That was one of the first signs J&J was willing to put the health of adolescent boys in jeopardy just to increase sales of its drug. The company is now facing more than 1,300 Risperdal breast growth lawsuit claims. The cases reveal more details on the extent to which Johnson & Johnson was willing to go to maximize its profits.
If you or your son experienced unnatural breast development as a Risperdal side effect, you’re not alone. Thousands of young men and boys are believed to suffer from the same circumstances. Please call 1-888-210-9968 to speak with our Risperdal attorneys and find out if you’re entitled to receive compensation.
J&J Pays A $2 Billion Fine Over Illegal Drug Marketing Charges
Drug companies are not allowed to advertise their prescription medicines for indications that have not received FDA approval. Prior to 2006, Risperdal had been cleared for use only by adults. Doctors could prescribe the medication to children if they thought the benefits outweighed the risk. But Johnson & Johnson was forbidden from marketing it to that end.
That didn’t stop J&J from doing so. According to charges filed by the U.S. Department of Justice, the drug maker marketed Risperdal for use among children long before 2006. The FDA repeatedly warned the company about its illegal marketing practices. The warnings seemed to have little effect.
The DOJ launched an investigation that culminated in a massive settlement. Johnson & Johnson agreed to pay $2.2 billion to settle the charges brought against it. Following the announcement, U.S. Attorney Zane Memeger noted “J&J’s promotion of Risperdal for unapproved uses threatened the most vulnerable populations of our society – children, the elderly and those with developmental disabilities.”
Risperdal Breast Growth Lawsuits Cite Fraudulent Misrepresentation
Plaintiffs involved in a Risperdal mass tort litigation in Philadelphia allege Johnson & Johnson knew its antipsychotic could stimulate breast enlargement in young boys. They claim the company was aware that gynecomastia and hyperprolactinemia (elevated prolactin levels) were among the drug’s potential side effects.
Instead of alerting parents and doctors about the danger, the pharmaceutical giant continued to promote its drug as safe for boys. Plaintiffs assert the company either knew or should have known that its portrayal of the drug as safe was false and misleading.
Lawsuits pending against J&J note that the company not only failed to conduct proper tests of Risperdal on adolescent boys, but deliberately concealed that fact. Its claims of safety were thus unfounded and a deliberate misrepresentation of the drug’s potential side effects.
Are You Eligible To Pursue A Risperdal Gynecomastia Settlement?
The manufacturer of Risperdal has shown an alarming zeal for violating drug-marketing laws in its pursuit of expanding sales of the medication. Unfortunately, the ones who have been most harmed are those who are least able to protect themselves: adolescents.
Abnormal breast enlargement is a traumatic experience for young males. It can introduce severe psychological impacts that impair self-esteem and social functioning. Parents with boys who developed female breasts after taking J&J’s antipsychotic are now seeking compensation for the emotional trauma that has burdened their families. They’re filing lawsuits against the manufacturer.
You can join the growing litigation. If you or a loved one experienced male breast growth after using Risperdal, call us toll-free at 1-888-210-9968 for a free case consultation. Our Risperdal gynecomastia attorneys will review the circumstances surrounding your case and answer any questions you have about filing a claim for compensation.
All claims are accepted on a contingency fee basis. If you decide to file a lawsuit, there are no out-of-pocket legal fees unless we win your case and recover compensation for you.
Contact our offices at your earliest convenience to receive the latest news about Risperdal lawsuit settlements and find out the filing deadline in your state. Our attorneys will explain your legal options and help you to obtain fair compensation for your family’s troubles.